Ruzicka BB

References (3)

Title : The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group - Raskind_1999_J.Clin.Psychiatry_60_318
Author(s) : Raskind MA , Cyrus PA , Ruzicka BB , Gulanski BI
Ref : J Clin Psychiatry , 60 :318 , 1999
PubMedID: 10362441

Title : Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease - Pettigrew_1998_J.Clin.Pharmacol_38_236
Author(s) : Pettigrew LC , Bieber F , Lettieri J , Wermeling DP , Schmitt FA , Tikhtman AJ , Ashford JW , Smith CD , Wekstein DR , Markesbery WR , Orazem J , Ruzicka BB , Mas J , Gulanski B
Ref : Journal of Clinical Pharmacology , 38 :236 , 1998
PubMedID: 98210831

Title : Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease [see comments] - Morris_1998_Neurology_50_1222
Author(s) : Morris JC , Cyrus PA , Orazem J , Mas J , Bieber F , Ruzicka BB , Gulanski B
Ref : Neurology , 50 :1222 , 1998
PubMedID: 9595967